Schedule 13G ownership disclosure
CALADRIUS BIOSCIENCES ORD
Security class unavailable · CUSIP: 128058203
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,505,367
- Percent of class
- 4.0200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-22-000336
- Form type
- SC 13G
- Filer
- LISATA THERAPEUTICS, INC.
- CIK
- CIK 320017
- Filed
- Jan 19, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership